Genetic Transformation 2011
DOI: 10.5772/22430
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Transformation of Triticeae Cereals for Molecular Farming

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 93 publications
(74 reference statements)
0
3
0
Order By: Relevance
“…Agrobacterium -mediated transformation of monocotyledonous species has been for a long time technically challenging, especially for cereals [ 48 , 49 ]. It took more than ten years after publishing the first successful Agrobacterium -mediated transformation of tobacco by De Block et al [ 50 ] to produce the transgenic plants in crops such as rice [ 51 ], and maize [ 52 ].…”
Section: Introductionmentioning
confidence: 99%
“…Agrobacterium -mediated transformation of monocotyledonous species has been for a long time technically challenging, especially for cereals [ 48 , 49 ]. It took more than ten years after publishing the first successful Agrobacterium -mediated transformation of tobacco by De Block et al [ 50 ] to produce the transgenic plants in crops such as rice [ 51 ], and maize [ 52 ].…”
Section: Introductionmentioning
confidence: 99%
“…Another step forward will be to study the relationship between this spatial, compositional information and grain properties, such as biomechanical properties that can affect the milling process. Progress towards establishing plants as a vehicle for the production of plant-made pharmaceuticals is likely to accelerate in the coming years (Hensel, 2011). The achievement of appropriate levels of expression remains somewhat empirical, and to a large extent varies from one recombinant protein to another (Hensel, 2011).…”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%
“…Progress towards establishing plants as a vehicle for the production of plant-made pharmaceuticals is likely to accelerate in the coming years (Hensel, 2011). The achievement of appropriate levels of expression remains somewhat empirical, and to a large extent varies from one recombinant protein to another (Hensel, 2011). Therefore, immunolabeling of recombinant proteins will be necessary in order to understand pathways and biochemical processes yet to be unraveled (Finnie, Sultan, & Grasser, 2011).…”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%